EVALUATION OF LABORATORY-IMMUNOLOGIC METHODS OF CARDIOVASCULAR PATHOLOGY IN PSORIATIC ARTHRITIS PATIENTS

dc.contributor.author	Abdullaev U.S.
dc.contributor.author	Abdullaev Ulugbek Sayfullaevich
dc.date.accessioned	2025-12-31T15:37:47Z
dc.date.issued	2023-08-22
dc.description.abstract	According to modern researchers, one of the most common comorbid diseases in patients with psoriatic arthritis (PsA) is cardiovascular disease (CVD). The presence of CVD in PsA increases the risk of cardiovascular complications (CVC) that lead to early disability in patients with this disease. In general, it was found that early diagnosis of CVD in PsA, not only can prevent CVC, but also can significantly improve the tactics of patient management, prevention of complications and improve the quality of life of patients with PsA
dc.format	application/pdf
dc.identifier.uri	https://scholarexpress.net/index.php/wbph/article/view/3103
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/49455
dc.language.iso	eng
dc.publisher	Scholar Express Journals
dc.relation	https://scholarexpress.net/index.php/wbph/article/view/3103/2659
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	World Bulletin of Public Health; Vol. 25 (2023): WBPH; 24-28
dc.source	2749-3644
dc.subject	psoriatic arthritis
dc.subject	cardiovascular diseases
dc.subject	laboratory-immunologic methods of research
dc.title	EVALUATION OF LABORATORY-IMMUNOLOGIC METHODS OF CARDIOVASCULAR PATHOLOGY IN PSORIATIC ARTHRITIS PATIENTS
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: us_2023_evaluation_of_laboratory-immunologic_met.pdf
item.page.filesection.size: 147.93 KB
item.page.filesection.format: Adobe Portable Document Format